Form D · Biotechnology
JUVARIS BIO THERAPEUTICS INC
Burlingame, CA · CIK 0001347758
Offering snapshot reported Oct 26, 2010 · SEC filing
- Reported sold
- $750K Offering amount: $2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 12, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 26, 2010 | Initial | $750,000 | No comparison | 3 | SEC filing |
| Sep 24, 2009 | Initial | $15,136,247 | No comparison | 3 | SEC filing |
| Dec 8, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 12, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 16, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-149574
Source: Form D, filed Oct 26, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carol L. Brosgart | Director |
| Kimberlee Gonzaga | Executive |
| Thomas P. Monath | Director |
| Grant E. Pickering | Director, Executive |
| Michael Ross | Director |
| Lewis T. Williams | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
866 Malcolm Road, Suite 100
Burlingame, CA, 94010
Burlingame, CA, 94010